Camrelizumab combined with gemcitabine and apatinib in treating advanced PD-L1-positive biliary tract cancers. [PDF]
Tian Y+11 more
europepmc +1 more source
S. clausii SF174 spores were effective in preventing the onset of low‐grade inflammation and insulin resistance induced by fructose‐rich diet in young rats, preserving the mitochondria from changes in the respiratory capacity in both liver and skeletal muscle, maintaining unaltered the oxidative balance, thus counteracting the deleterious effects of ...
Angela Di Porzio+7 more
wiley +1 more source
Recent Advances in Immunotherapy for Advanced Biliary Tract Cancer. [PDF]
Yue S, Zhang Y, Zhang W.
europepmc +1 more source
Prognostic Significance of Lymphocyte-to-Monocyte Ratio in Patients With Unresectable Biliary Tract Cancer Undergoing Systemic Chemotherapy. [PDF]
Suzuki H+5 more
europepmc +1 more source
Targeting gut microbiota as a therapeutic approach for neurodegenerative diseases
The abstract depicts the gut‐brain axis, illustrating the bidirectional communication between the gastrointestinal tract and the central nervous system. Probiotics can induce the production of neurotrophins, neurotransmitters, SCFAs, and contribute to increased antioxidant levels, which can benefit brain health. In contrast, antibiotics can disrupt the
Tobiloba S. Olajide+1 more
wiley +1 more source
Cost-effectiveness analysis of pembrolizumab plus chemotherapy as first-line treatment for advanced biliary tract cancer: perspectives from US and Chinese payers. [PDF]
Jiang C, Zhou K, Shu P.
europepmc +1 more source
Treatment Patterns and Outcomes in Patients with Advanced Biliary Tract Cancers Treated with Gemcitabine-Based Chemotherapy: A Retrospective Study. [PDF]
Dayyani F+6 more
europepmc +1 more source
Psychological distress in biliary tract malignancy patients: influencing factors and development of a predictive nomogram model. [PDF]
Gou Z+8 more
europepmc +1 more source
Integration of circulating tumor DNA in biliary tract cancer: the emerging landscape. [PDF]
Awosika JA, Monge C, Greten TF.
europepmc +1 more source